Graf Akcie ALXN (Alexion Pharmaceuticals Inc.). Diskuze k akciím ALXN. Aktuální informace ALXN.

Základní informace o společnosti Alexion Pharmaceuticals Inc. (Akcie ALXN)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace	40.34B
Hodnota podniku (EV)	N/A
Tržby	6.262B
EBITDA	3.18B
Zisk	681.8M
Růst v tržbách Q/Q	13.27 %
Růst v tržbách Y/Y	18.24 %
P/E (Cena vůči ziskům)	58.49
Forward P/E	N/A
EV/Sales	6.32
EV/EBITDA	N/A
EV/EBIT	51.25
PEG	1.17
Price/Sales	6.47
P/FCF	13.55
Price/Book	3.46
Účetní hodnota na akcii	52.72
Hotovost na akcii	13.57
FCF vůči ceně	7.38 %
Počet zaměstnanců	2,525
Tržba na zaměstnance	2480000
Profit margin	9.94 %
Operating margin	47.41 %
Gross margin	90.88 %
EBIT margin	12.15 %
EBITDA margin	50.79 %

EPS - Zisk na akcii	3.12
EPS - Kvartální růst	9.32 %
EPS - Očekávaný růst příští rok	7.07 %
Return on assets	10.08 %
Return on equity	4.43 %
ROIC	3.78 %
ROCE	4.42 %
Dluhy/Equity	0.55
Čistý dluh/EBITDA	-0.25
Current ratio	4.52
Quick Ratio	3.47
Volatilita	1.17
Beta	0.00
RSI	52.18
Cílová cena analytiků	146
Známka akcie (dle analytiků)	1.92
Insider ownership	0.34 %
Institutional ownership	88.27 %
Počet akcií	221.019M
Procento shortovaných akcií	3.84 %
Short ratio	4.24 %
Dividenda	N/A
Procentuální dividenda	N/A %
Dividenda/Zisk	N/A %
Obchodovaná od	1996
Země	United States

Finanční výsledky akcie ALXN

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

#	2020	2019	2018	2017	2016	2015
Revenue	$6,069.9	$4,991.1	$4,131.2	$3,551.1	$3,084.1	$2,604
Cost Of Goods Sold	$553.5	$394.5	$374.3	$454.2	$258.3	$233.1
Gross Profit	$5,516.4	$4,596.6	$3,756.9	$3,096.9	$2,825.8	$2,370.9
Research And Development Expenses	$1,002.9	$886	$730.4	$878.4	$757.2	$709.5
SG&A Expenses	$1,399.9	$1,261.1	$1,111.8	$1,094.4	$953	$862.6
Other Operating Income Or Expenses	$-2,099.7	$-11.6	$-116.5	$-72	$-120.7	$-64.2
Operating Expenses	$5,437.6	$2,870.7	$3,861.6	$2,923.7	$2,416.7	$2,067.3
Operating Income	$632.3	$2,120.4	$269.6	$627.4	$667.4	$536.7
Total Non-Operating Income/Expense	$-63.3	$58.4	$-27.4	$-79.6	$-91.2	$-38.6
Pre-Tax Income	$569	$2,178.8	$242.2	$547.8	$576.2	$498.1
Income Taxes	$-34.4	$-225.5	$164.6	$104.5	$176.8	$353.7
Income After Taxes	$603.4	$2,404.3	$77.6	$443.3	$399.4	$144.4
Other Income	-	-	-	-	-	-
Income From Continuous Operations	$603.4	$2,404.3	$77.6	$443.3	$399.4	$144.4
Income From Discontinued Operations	-	-	-	-	-	-
Net Income	$603.4	$2,404.3	$77.6	$443.3	$399.4	$144.4
EBITDA	$3,015	$2,497.2	$688.4	$1,124.1	$1,063.8	$703.3
EBIT	$632.3	$2,120.4	$269.6	$627.4	$667.4	$536.7
Basic Shares Outstanding	220	223	223	224	224	213
Shares Outstanding	222	225	225	225	226	216
Basic EPS	$2.74	$10.77	$0.35	$1.98	$1.78	$0.68
EPS - Earnings Per Share	$2.72	$10.70	$0.35	$1.97	$1.76	$0.67

#	2020	2019	2018	2017	2016	2015
Cash On Hand	$2,999.4	$2,749.5	$1,563.8	$1,474.1	$1,293.4	$1,385
Receivables	$1,409.3	$1,243.2	$922.3	$726.5	$649.6	$533
Inventory	$775.7	$627.6	$472.5	$460.4	$374.7	$290
Pre-Paid Expenses	$648.6	$456.1	$426.4	$292.9	$260.5	$208
Other Current Assets	-	-	-	-	-	-
Total Current Assets	$5,833	$5,076.4	$3,385	$2,953.9	$2,578.2	$2,416
Property, Plant, And Equipment	$1,238.8	$1,163.3	$1,471.5	$1,325.4	$1,035.6	$697
Long-Term Investments	-	-	-	-	-	-
Goodwill And Intangible Assets	$8,102.5	$8,381.7	$8,678.7	$8,991.8	$9,340.5	$9,756
Other Long-Term Assets	$506.2	$429	$294.9	$312.2	$299	$228
Total Long-Term Assets	$12,270	$12,468.2	$10,546.9	$10,629.4	$10,675.1	$10,681
Total Assets	$18,103	$17,544.6	$13,931.9	$13,583.3	$13,253.3	$13,097
Total Current Liabilities	$1,624.7	$1,194.3	$1,174	$952.5	$822.9	$709
Long Term Debt	$2,419.6	$2,375	$2,862.7	$3,063.6	$3,121.5	$3,405
Other Non-Current Liabilities	$598.2	$458	$338.8	$309.1	$219.6	$195
Total Long Term Liabilities	$4,827.1	$5,078.5	$3,592.6	$3,737.7	$3,736.6	$4,129
Total Liabilities	$6,451.8	$6,272.8	$4,766.6	$4,690.2	$4,559.5	$4,838
Common Stock Net	-	-	-	-	-	-
Retained Earnings (Accumulated Deficit)	$5,243.2	$4,639.8	$2,325.8	$2,242.1	$1,817.6	$1,181
Comprehensive Income	$-124.6	$-66.8	$-9.7	$-34.4	$60.5	$62
Other Share Holders Equity	-	-	-	-	-	-
Share Holder Equity	$11,651.2	$11,271.8	$9,165.3	$8,893.1	$8,693.8	$8,259
Total Liabilities And Share Holders Equity	$18,103	$17,544.6	$13,931.9	$13,583.3	$13,253.3	$13,097

#	2020	2019	2018	2017	2016	2015
Net Income/Loss	$603.4	$2,404.3	$77.6	$443.3	$399.4	$144.4
Total Depreciation And Amortization - Cash Flow	$2,382.7	$376.8	$418.8	$496.7	$396.4	$166.6
Other Non-Cash Items	$50.6	$-416.5	$384.3	$346.1	$427.1	$779.4
Total Non-Cash Items	$2,433.3	$-39.7	$803.1	$842.8	$823.5	$946
Change In Accounts Receivable	$-139.4	$-319.2	$-208.8	$-55.2	$-122.1	$-115.8
Change In Inventories	$95	$-160.2	$-35.2	$-88.2	$-83.8	$-88.4
Change In Accounts Payable	-	-	-	-	-	-
Change In Assets/Liabilities	$-111.9	$-31	$-155.6	$-137.2	$-97.5	$-95.1
Total Change In Assets/Liabilities	$-33.8	$-279.7	$-454.7	$-170.5	$-136.6	$-415.2
Cash Flow From Operating Activities	$3,002.9	$2,084.9	$426	$1,115.6	$1,086.3	$675.2
Net Change In Property, Plant, And Equipment	$-106.7	$-154.7	$-213	$-357.3	$-332.7	$-286.3
Net Change In Intangible Assets	-	$-16	-	-	-	-
Net Acquisitions/Divestitures	$-2,111.9	-	-	-	-	$-3,939.3
Net Change In Short-term Investments	$119.1	$180.5	$680.7	$-561.1	$46.2	$635
Net Change In Long-Term Investments	-	-	-	-	-	-
Net Change In Investments - Total	$119.1	$180.5	$680.7	$-561.1	$46.2	$635
Investing Activities - Other	-	$-0.1	$2.8	$0.1	$-1.1	$5.4
Cash Flow From Investing Activities	$-2,099.5	$9.7	$470.5	$-918.3	$-287.6	$-3,585.2
Net Long-Term Debt	$-130.6	$-98	$-293.8	$-175	$-375	$3,398.8
Net Current Debt	-	$-250	$250	-	-	-
Debt Issuance/Retirement Net - Total	$-130.6	$-348	$-43.8	$-175	$-375	$3,398.8
Net Common Equity Issued/Repurchased	$-510.8	$-416	$-85	$-463.6	$-393.5	$-245.7
Net Total Equity Issued/Repurchased	$-510.8	$-416	$-85	$-463.6	$-393.5	$-245.7
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-
Financial Activities - Other	$29.5	$24.9	$26.4	$42	$-67.7	$-168
Cash Flow From Financial Activities	$-611.9	$-739.1	$-102.4	$-596.6	$-836.2	$2,985.1
Net Cash Flow	$311	$1,356.3	$782.9	$-381.6	$-44.1	$66.1
Stock-Based Compensation	$281.1	$237	$203	$243.1	$192.3	$227.1
Common Stock Dividends Paid	-	-	-	-	-	-

#	2020	2019	2018	2017	2016	2015
Current Ratio	3.5902	4.2505	2.8833	3.1012	3.1331	3.4076
Long-term Debt / Capital	0.172	0.174	0.238	0.2562	0.2642	0.2919
Debt/Equity Ratio	0.2199	0.2219	0.3499	0.3633	0.3783	0.4392
Gross Margin	90.8812	92.0959	90.9397	87.2096	91.6248	91.0484
Operating Margin	10.417	42.4836	6.526	17.6678	21.64	20.6106
EBIT Margin	10.417	42.4836	6.526	17.6678	21.64	20.6106
EBITDA Margin	49.6713	50.0331	16.6634	31.655	34.4931	27.0085
Pre-Tax Profit Margin	9.3741	43.6537	5.8627	15.4262	18.6829	19.1283
Net Profit Margin	9.9409	48.1718	1.8784	12.4835	12.9503	5.5453
Asset Turnover	0.3353	0.2845	0.2965	0.2614	0.2327	0.1988
Inventory Turnover Ratio	0.7135	0.6286	0.7922	0.9865	0.6894	0.8038
Receiveable Turnover	4.307	4.0147	4.4792	4.888	4.7477	4.8856
Days Sales In Receivables	84.7451	90.9154	81.4871	74.6733	76.8795	74.7101
ROE - Return On Equity	5.1789	21.3302	0.8467	4.9848	4.5941	1.7484
Return On Tangible Equity	17.0034	83.1909	15.9474	-449.1379	-61.7597	-9.646
ROA - Return On Assets	3.3331	13.7039	0.557	3.2636	3.0136	1.1025
ROI - Return On Investment	4.2883	17.6181	0.6452	3.7075	3.3804	1.238
Book Value Per Share	53.0806	50.9345	41.0081	40.005	38.8289	36.7067
Operating Cash Flow Per Share	4.2521	7.3769	-3.0518	0.1491	1.6729	-0.0409
Free Cash Flow Per Share	4.4597	7.6375	-2.4154	0.0341	1.5288	-0.6888

Premium

Tento článek patří k prémiovému obsahu našeho webu.

Již mám předplatné

Roční předplatné

Ušetříte 589 Kč oproti měsíčnímu předplatnému

2 999Kč

Objednat

Čtvrtletní předplatné

Ušetříte 98 Kč oproti měsíčnímu předplatnému

799Kč

Objednat

Měsíční předplatné

Předplatné našich prémiových služeb na měsíc.

299Kč

Objednat

Porovnání s konkurencí: Akcie ALXN

Společnost	P/E	PEG	Růst v tržbách (roční)	Růst v EPS	Return on equity	P/B	Profit margin
ALXN	58.49	1.17	18.24 %	7.07 %	4.43 %	3.46	9.94 %
Akcie AGIO	1.94	N/A	N/A %	11.19 %	129.96 %	6.48	-161.11 %
Akcie BIIB	22.44	6.24	-19.26 %	-53.28 %	17.89 %	4.05	29.76 %
Akcie GILD	16.52	0.56	20.13 %	-20.85 %	27.79 %	4.70	0.50 %
Akcie JNJ	23.88	1.67	10.79 %	7.27 %	27.01 %	6.71	17.82 %
Akcie RARE	N/A	N/A	125.44 %	23.01 %	-36.54 %	4.77	-68.84 %
Akcie REGN	9.37	1.21	54.84 %	7.66 %	51.44 %	5.30	41.35 %
Akcie SRPT	N/A	77.40	33.29 %	-21.60 %	-94.90 %	9.98	-102.60 %
Akcie VRTX	23.44	0.36	23.71 %	15.91 %	22.76 %	5.39	43.70 %

Nedávné obchody insiderů: Akcie ALXN

Jméno	Obchod	Cena	Objem
Indrani Lall Franchini EVP and Chief Compliance Officer	Prodej 28 Nov 2018	$118.13	$307,729
Ludwig Hantson CEO	Prodej 31 Dec 2018	$95.85	$310,937
Daniel Bazarko SVP, Controller, and CAO	Prodej 14 Feb 2019	$126.00	$252,000
Bros. Advisors Lp667, L.P.B...	Prodej 28 May 2019	$123.74	$37,122,000
Aradhana Sarin EVP and CFO	Prodej 21 Jun 2019	$132.00	$76,296
Indrani Lall Franchini EVP and Chief Compliance Officer	Prodej 1 Jul 2019	$132.78	$597,510
Bros. Advisors Lp667, L.P.B...	Nákup 16 Mar 2020	$78.33	$32,790,583
Bros. Advisors Lp667, L.P.B...	Nákup 18 Mar 2020	$82.01	$6,673,892
Indrani Lall Franchini EVP and Chief Compliance Officer	Prodej 8 Jun 2020	$114.69	$785,971
Tanisha Carino EVP and CCAO	Prodej 2 Dec 2020	$122.26	$187,058
Daniel Bazarko SVP, Controller, and CAO	Option 17 Dec 2020	$117.04	$2,816,685
Indrani Lall Franchini EVP and Chief Compliance Officer	Prodej 28 Nov 2018	$118.13	$307,729
Ludwig Hantson CEO	Prodej 31 Dec 2018	$95.85	$310,937
Daniel Bazarko SVP, Controller, and CAO	Prodej 14 Feb 2019	$126.00	$252,000
Bros. Advisors Lp667, L.P.B...	Prodej 28 May 2019	$123.74	$37,122,000
Aradhana Sarin EVP and CFO	Prodej 21 Jun 2019	$132.00	$76,296
Indrani Lall Franchini EVP and Chief Compliance Officer	Prodej 1 Jul 2019	$132.78	$597,510
Bros. Advisors Lp667, L.P.B...	Nákup 16 Mar 2020	$78.33	$32,790,583
Bros. Advisors Lp667, L.P.B...	Nákup 18 Mar 2020	$82.01	$6,673,892
Indrani Lall Franchini EVP and Chief Compliance Officer	Prodej 8 Jun 2020	$114.69	$785,971
Tanisha Carino EVP and CCAO	Prodej 2 Dec 2020	$122.26	$187,058
Daniel Bazarko SVP, Controller, and CAO	Option 17 Dec 2020	$117.04	$2,816,685

JenAkcie

Graf Akcie ALXN (Alexion Pharmaceuticals Inc.). Diskuze k akciím ALXN. Aktuální informace ALXN.

Základní informace o společnosti Alexion Pharmaceuticals Inc. (Akcie ALXN)

Finanční výsledky akcie ALXN

Tento článek patří k prémiovému obsahu našeho webu.

Roční předplatné

Čtvrtletní předplatné

Měsíční předplatné

Porovnání s konkurencí: Akcie ALXN

Nedávné obchody insiderů: Akcie ALXN

Diskuze k akciím ALXN